Reinfection with Mycobacterium tuberculosis in an urban tuberculosis hospital

Clinical Microbiology and Infection

Volumn 4, Issue 1, 1998, Pages 49-51

  Pillay, Manormoney ^a   Onyebujoh, Philip ^b   Sturm, A Willem ^a  

^a UNIVERSITY OF NATAL   (South Africa)

^b SOUTH AFRICAN MEDICAL RESEARCH COUNCIL   (South Africa)

Author keywords

[No Author keywords available]

Indexed keywords

ETHAMBUTOL; ISONIAZID; PYRAZINAMIDE; RIFAMPICIN; TUBERCULOSTATIC AGENT;

ARTICLE; CLINICAL ARTICLE; DNA FINGERPRINTING; HOSPITAL; HOSPITAL INFECTION; HUMAN; MYCOBACTERIUM TUBERCULOSIS; PRIORITY JOURNAL; REINFECTION; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; STRAIN DIFFERENCE; TUBERCULOSIS; URBAN AREA;

MYCOBACTERIUM; MYCOBACTERIUM TUBERCULOSIS;

EID: 0031964258     PISSN: 1198743X     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1469-0691.1998.tb00335.x     Document Type: Article

References (5)

1. Van Embden JDA, Cave MD, Crawford JT, et al. Strain identification of Mycobacterium tuberculosis by DNA finger-printing: recommendations for a standardized methodology. J Clin Microbiol 1993; 31: 406-9.
2. Singhal M, Banavalikar JN, Sharma S, Saha K. Peripheral blood T lymphocyte subpopulations in patients with TB and the effect of chemotherapy. Tubercle 1989; 70: 171-8.
3. Ainslie GM, Solomon JA, Bateman ED. Lymphocyte and lymphocyte subset numbers in blood and in bronchoalveolar lavage and pleural fluid in various forms of human pulmonary TB at presentation and during recovery. Thorax 1992; 47: 513-18.
4. Report on the review of the tuberculosis program of South Africa Department of Health, Republic of South Africa. Epidemiol Comments 1996; 23(1): 2-20.
5. Tuberculosis research and development: report of a WHO meeting, Geneva, 23-25 October 1990.